Cargando…
Correction to: Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study
Autores principales: | Emral, Rifat, Haymana, Cem, Demirci, Ibrahim, Tasci, Ilker, Sahin, Mustafa, Cakal, Erman, Ata, Naim, Unluturk, Ugur, Demir, Tevfik, Ertugrul, Derun, Sahin, Ibrahim, Atmaca, Aysegül, Celik, Osman, Caglayan, Murat, Arga, Kazim Yalcin, Dagdelen, Selcuk, Salman, Serpil, Satman, Ilhan, Sonmez, Alper |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461138/ https://www.ncbi.nlm.nih.gov/pubmed/34559403 http://dx.doi.org/10.1007/s13300-021-01154-3 |
Ejemplares similares
-
Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study
por: Emral, Rifat, et al.
Publicado: (2021) -
Unexpectedly lower mortality rates in COVID-19 patients with and without type 2 diabetes in Istanbul
por: Satman, Ilhan, et al.
Publicado: (2021) -
Clinical outcomes of non-diabetic COVID-19 patients with different blood glucose levels: a nationwide Turkish study (TurCoGlycemia)
por: Haymana, Cem, et al.
Publicado: (2021) -
No association of anti-osteoporosis drugs with COVID-19-related outcomes in women: a nationwide cohort study
por: Atmaca, A., et al.
Publicado: (2021) -
Rates and associates of influenza and pneumococcus vaccination in diabetes mellitus: A nationwide cross-sectional study (TEMD vaccination study)
por: Demirci, Ibrahim, et al.
Publicado: (2021)